Literature DB >> 33180651

The effect of sex on responses to influenza vaccines.

Lucy Denly1.   

Abstract

The poor uptake and limited effectiveness of seasonal influenza vaccines mean that influenza continues to create a significant burden of disease. It has been hypothesized that sex differences are present in responses to seasonal influenza vaccines, and that these differences may contribute to this poor vaccine success. This has led to the suggestion that vaccines should be tailored to an individual's biological sex. However, studies in this field are often low quality. Comprehensive analysis of the available literature reveals that there is insufficient evidence to support sex differences in vaccine immunogenicity, effectiveness, or efficacy. Nonetheless, differences in vaccine safety are consistently observed, with females reporting adverse events following immunization more frequently than males. Bias introduced by gender differences in passive reporting of adverse effects may underlie this phenomenon. Highly controlled studies are required in future before any conclusions can be made about potential sex differences in response to seasonal influenza vaccines.

Keywords:  Seasonal influenza vaccine; sex differences; vaccine effectiveness; vaccine efficacy; vaccine immunogenicity; vaccine safety

Mesh:

Substances:

Year:  2020        PMID: 33180651      PMCID: PMC8078729          DOI: 10.1080/21645515.2020.1830685

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  59 in total

1.  Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults.

Authors:  Luis Rivera; Sonia Mazara; Maria Vargas; Elena Fragapane; Daniela Casula; Nicola Groth
Journal:  Vaccine       Date:  2012-05-31       Impact factor: 3.641

2.  Mouse strain and sex as determinants of immune response to trivalent influenza vaccine.

Authors:  Raisa Petrović; Biljana Bufan; Nevena Arsenović-Ranin; Irena Živković; Rajna Minić; Katarina Radojević; Gordana Leposavić
Journal:  Life Sci       Date:  2018-05-31       Impact factor: 5.037

3.  Influenza Vaccines: Good, but We Can Do Better.

Authors:  Catharine I Paules; Anthony S Fauci
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

4.  Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.

Authors:  Ramona Trebbien; Thea K Fischer; Tyra G Krause; Lene Nielsen; Xiaohui Chen Nielsen; Lenette Sandborg Weinreich; Joanna Lis-Tønder; Marianne Nielsine Skov; Claus Bohn Christiansen; Hanne-Dorthe Emborg
Journal:  J Clin Virol       Date:  2017-06-29       Impact factor: 3.168

5.  Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.

Authors:  Victor C Huber; Raelene M McKeon; Martha N Brackin; Laura A Miller; Rachael Keating; Scott A Brown; Natalia Makarova; Daniel R Perez; Gene H Macdonald; Jonathan A McCullers
Journal:  Clin Vaccine Immunol       Date:  2006-09

6.  Effectiveness of seasonal vaccine in preventing confirmed influenza-associated hospitalizations in community dwelling older adults.

Authors:  H Keipp Talbot; Marie R Griffin; Qingxia Chen; Yuwei Zhu; John V Williams; Kathryn M Edwards
Journal:  J Infect Dis       Date:  2011-01-10       Impact factor: 5.226

7.  Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons.

Authors:  Rongxia Li; Brock Stewart; Michael M McNeil; Jonathan Duffy; Jennifer Nelson; Alison Tse Kawai; Roger Baxter; Edward A Belongia; Eric Weintraub
Journal:  Pharmacoepidemiol Drug Saf       Date:  2016-04-01       Impact factor: 2.890

8.  The confounded effects of age and exposure history in response to influenza vaccination.

Authors:  Ana Mosterín Höpping; Janet McElhaney; Judith M Fonville; Douglas C Powers; Walter E P Beyer; Derek J Smith
Journal:  Vaccine       Date:  2015-12-05       Impact factor: 3.641

Review 9.  Assessing sex-differences and the effect of timing of vaccination on immunogenicity, reactogenicity and efficacy of vaccines in young children: study protocol for an individual participant data meta-analysis of randomised controlled trials.

Authors:  Merryn Voysey; Andrew J Pollard; Rafael Perera; Thomas R Fanshawe
Journal:  BMJ Open       Date:  2016-07-29       Impact factor: 2.692

10.  Age-associated changes in the impact of sex steroids on influenza vaccine responses in males and females.

Authors:  Tanvi Potluri; Ashley L Fink; Kristyn E Sylvia; Santosh Dhakal; Meghan S Vermillion; Landon Vom Steeg; Sharvari Deshpande; Harish Narasimhan; Sabra L Klein
Journal:  NPJ Vaccines       Date:  2019-07-12       Impact factor: 7.344

View more
  4 in total

1.  Proteomic assessment of humoral immune responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Diane E Grill; Gregory A Poland
Journal:  Vaccine       Date:  2021-12-21       Impact factor: 3.641

2.  Gender Differences in Adverse Events Following the Pfizer-BioNTech COVID-19 Vaccine.

Authors:  Manfred S Green; Victoria Peer; Avi Magid; Neta Hagani; Emilia Anis; Dorit Nitzan
Journal:  Vaccines (Basel)       Date:  2022-02-03

3.  Impact of adjuvant: Trivalent vaccine with quadrivalent-like protection against heterologous Yamagata-lineage influenza B virus.

Authors:  Mallory L Myers; John R Gallagher; De'Marcus D Woolfork; Regan K Stradtmann-Carvalho; Samantha Maldonado-Puga; Kevin W Bock; Seyhan Boyoglu-Barnum; Hubza Syeda; Adrian Creanga; Derron A Alves; Masaru Kanekiyo; Audray K Harris
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

4.  The impact of circadian rhythms on the immune response to influenza vaccination in middle-aged and older adults (IMPROVE): a randomised controlled trial.

Authors:  Yihao Liu; Hui Zhang; Gang Yuan; Mi Yao; Bin Li; Jianying Chen; Yuling Fan; Ruohui Mo; Fenghua Lai; Xinwen Chen; Mengyuan Li; Binfeng Chen; Janet M Lord; Sui Peng; KarKeung Cheng; Haipeng Xiao
Journal:  Immun Ageing       Date:  2022-10-17       Impact factor: 9.701

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.